TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Movers: OncoMed Tanks After Barrage of Bad News, Geron Spikes on New Data

Medivation Founder Takes Helm at Axovant, Shares Spike
STOCKS

Medivation Founder Takes Helm at Axovant, Shares Spike

Clovis Spikes on Phase 3 Data for Ovarian Cancer Drug- Biotech Movers
STOCKS

Clovis, Tesaro soar on AstraZeneca phase three news

10 Highest-Paying Jobs in 2016 If All You Care About Is Money
STOCKS

Biotech Tesaro climbs on takeout reports

2016 Was a Terrible Year for Biotech but the Tweets Were on Point
STOCKS

2016 was a terrible year for biotech but the tweets were on point

What to Look For When Pfizer (PFE) Posts Q1 Results
STOCKS

Pfizer finds breaking up is hard to do

Sanofi Strikes $11.6 Billion Deal for Bioverativ
STOCKS

Sanofi gains boost from MS treatments as diabetes drug Lantus flounders

Merck Is a 'Risk Worth Taking' in Spite of Trump Comments, Top Trader Claims
STOCKS

After FDA approval, merck posts better-than-expected earnings

Sanofi, Merck and J&J Tout Lower Drug Prices
STOCKS

What to watch in Sanofi's third-quarter results

Clovis Spikes on Phase 3 Data for Ovarian Cancer Drug- Biotech Movers
STOCKS

Guide to Clovis, Tesaro ovarian cancer drug updates

Pfizer Announces Big Reorganization As It Continues Trying to Sell Consumer Biz
STOCKS

Read scraps Pfizer break-up as megadeals escape its grasp

10 Highest-Paying Jobs in 2016 If All You Care About Is Money
MERGERS AND ACQUISITIONS

Takeover chatter around Clovis may be overdone

Sanofi, Merck and J&J Tout Lower Drug Prices
INVESTING

New setback for Sanofi's Lantus increases need for m&a

Medivation (MDVN) Stock Receives ‘Market Perform’ Rating at BMO Capital
MERGERS AND ACQUISITIONS

Medivation proxy shows Pfizer battled four bidders to seal a deal

Jim Cramer's 'Mad Money' Recap: The Urge to Merge Rules Wall Street
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: The Urge to Merge Rules Wall Street

Pfizer Is Buying a Portion of AstraZeneca's Antibiotics Business
VIDEO

Pfizer Is Buying a Portion of AstraZeneca's Antibiotics Business

Pfizer Firing on All Cylinders
MERGERS AND ACQUISITIONS

Why pfizer's latest deal could send its shares soaring

5 Things You Must Know Before the Market Opens Wednesday
FUTURES

5 things you must know before the market opens Wednesday

Medivation (MDVN) Stock Receives ‘Market Perform’ Rating at BMO Capital
MARKETS

Medivation (MDVN) Stock Downgraded After Pfizer Deal

Jim Cramer's 'Mad Money' Recap: I'm Watching Best Buy, PVH, Yellen This Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: I'm Watching Best Buy, PVH, Yellen This Week

Fed Chair Janet Yellen to Consumers: Chill, It's All Good
FUTURES

Stocks waver as investors wait for Fed clarity

Dozens Injured in New York City After Subway Derailment
FUTURES

Stocks struggle for direction as Jackson Hole conference looms

Medivation (MDVN) Stock Receives ‘Market Perform’ Rating at BMO Capital
MERGERS AND ACQUISITIONS

Medivation Scores Premium in Sale to Pfizer

Pfizer's Deal to Buy Medivation May Give the Company Its Groove Back
VIDEO

Pfizer's Deal to Buy Medivation May Give the Company Its Groove Back

Credit Suisse's 5 Large-Cap Oil Stock Favorites Ahead of Earnings
FUTURES

Crude selloff, health care rally split wall street